Atlas Trials

Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder

Clinical trial NCT06538558 · RECRUITING

Trial details

NCT number
NCT06538558
Sponsor
Proniras Corporation
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Opioid Use Disorder
Start date
2024-10-16
Primary completion
2025-10-14
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.